WO2001034795A3 - Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis - Google Patents

Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis Download PDF

Info

Publication number
WO2001034795A3
WO2001034795A3 PCT/EP2000/011035 EP0011035W WO0134795A3 WO 2001034795 A3 WO2001034795 A3 WO 2001034795A3 EP 0011035 W EP0011035 W EP 0011035W WO 0134795 A3 WO0134795 A3 WO 0134795A3
Authority
WO
WIPO (PCT)
Prior art keywords
casb7435
polypeptide
diagnosis
treatment
nucleic acid
Prior art date
Application number
PCT/EP2000/011035
Other languages
French (fr)
Other versions
WO2001034795A2 (en
Inventor
Y De Bassols Carlota Vinals
Thierry Coche
Jean-Pol Cassart
Swann Roman Jean-Thomas Gaulis
Original Assignee
Smithkline Beecham Biolog
Y De Bassols Carlota Vinals
Thierry Coche
Cassart Jean Pol
Gaulis Swann Roman Jean Thomas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog, Y De Bassols Carlota Vinals, Thierry Coche, Cassart Jean Pol, Gaulis Swann Roman Jean Thomas filed Critical Smithkline Beecham Biolog
Priority to AU15199/01A priority Critical patent/AU1519901A/en
Publication of WO2001034795A2 publication Critical patent/WO2001034795A2/en
Publication of WO2001034795A3 publication Critical patent/WO2001034795A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

CASB7435 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7435 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
PCT/EP2000/011035 1999-11-09 2000-11-08 Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis WO2001034795A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15199/01A AU1519901A (en) 1999-11-09 2000-11-08 Novel compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9926532.4 1999-11-09
GBGB9926532.4A GB9926532D0 (en) 1999-11-09 1999-11-09 Novel compounds

Publications (2)

Publication Number Publication Date
WO2001034795A2 WO2001034795A2 (en) 2001-05-17
WO2001034795A3 true WO2001034795A3 (en) 2002-01-24

Family

ID=10864233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011035 WO2001034795A2 (en) 1999-11-09 2000-11-08 Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis

Country Status (3)

Country Link
AU (1) AU1519901A (en)
GB (1) GB9926532D0 (en)
WO (1) WO2001034795A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LEE YOUNG-CHOON ET AL: "Molecular cloning and functional expression of two members of mouse NeuAcalpha2,3Galbeta1,3GalNAc GalNAcalpha2,6-sialyltransferase family, ST6GalNAc III and IV.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 17, 23 April 1999 (1999-04-23), pages 11958 - 11967, XP002173868, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2001034795A2 (en) 2001-05-17
GB9926532D0 (en) 2000-01-12
AU1519901A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
WO2001062778A3 (en) Tumour-specific animal proteins
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2001008635A3 (en) Calcium channel transport polynucleotides, polypeptides, and antibodies
WO2000053748A3 (en) Casb618 polynucleotides and polypeptides and their use
WO2000058460A3 (en) Casb619 involved in colon cancers
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2000061774A3 (en) Bone morphogenic proteins
WO2003031571A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2001034795A3 (en) Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis
WO2003031586A3 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2001032878A3 (en) A novel polypeptide hormone phosphatonin
WO2000043509A3 (en) Polynucleotides and their applications in diagnostics
WO2003055905A3 (en) Proteins of non typable haemophilus influenzae
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
WO2001023417A3 (en) Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
WO2002081629A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003052061A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002024729A3 (en) Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
WO2003064589A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002072770A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003004617A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2002100891A3 (en) Proteins derived from non-typable haemophilus influenzae (nthi) strain
WO2003050245A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)